Telitacicept Treatment Refractory Lupus Nephritis: A Case Report

被引：3

作者：

Li, Sijia ^{[1
]}

Deng, Shuting ^{[2
]}

Wen, Sichun ^{[1
]}

Peng, Siqi ^{[1
]}

Jiang, Nan ^{[1
]}

Li, Bohou ^{[1
]}

Chen, Boxi ^{[1
]}

Yuan, Ye ^{[1
]}

Wu, Qiong ^{[1
]}

Tao, Yiming ^{[1
]}

Ma, Jianchao ^{[1
]}

Lin, Ting ^{[1
]}

Wen, Feng ^{[1
]}

Li, Zhuo ^{[1
]}

Dai, Hao ^{[1
]}

Huang, Renwei ^{[1
]}

Feng, Zhonglin ^{[1
]}

Li, Zhilian ^{[1
]}

Liu, Shuangxin ^{[1
]}

Xu, Lixia ^{[1
]}

机构：

[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Nephrol, Guangzhou, Peoples R China

[2] South China Univ Technol, Sch Med, Guangzhou, Peoples R China

来源：

CASE REPORTS IN NEPHROLOGY AND DIALYSIS | 2024年 / 14卷 / 01期

关键词：

Systemic lupus erythematosus; Refractory lupus nephritis; Telitacicept; Biologics; Treatment; MANAGEMENT;

D O I：

10.1159/000538033

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Refractory lupus nephritis (LN) causes kidney disease progression and increases the risk of loss of renal function. Due to the high specificity and few side effects of biological agents, they are recommended for the treatment of systemic lupus erythematosus. There are few data on telitacicept for the treatment of refractory LN. Case Presentation: Here, we report the efficacy and safety of telitacicept in the treatment of refractory LN in a 25-year-old female patient. This patient with refractory lupus developed Pneumocystis jirovecii pneumonia while using multitargeted therapy, and the patient's urine protein was rapidly relieved after telitacicept combination with low-dose mycophenolate mofetil (MMF). Conclusion: This result suggests that telitacicept has a positive effect on refractory LN with no significant side effects. Further reports and a registry are necessary to confirm that telitacicept with low-dose MMF should be preferred in refractory LN.

引用

页码：42 / 47

页数：6

共 50 条

[31] TREATMENT OF REFRACTORY LUPUS NEPHRITIS WITH B LYMPHOCYTE DEPLETION
Leandro, M. J.
Ehrenstein, M. R.
Edwards, J. C. W.
Manson, J.
Cambridge, G.
Isenberg, D. A.
RHEUMATOLOGY, 2004, 43 : 109 - 110
[32] Successful treatment of refractory systemic lupus erythematosus-associated immune thrombocytopenia with drug-induced liver injury with telitacicept: a case report and review
Li, Xuefei
Fu, Yao
Yin, Haiqin
Zhu, Huiling
FRONTIERS IN IMMUNOLOGY, 2025, 16
[33] Surgery and antibiotics for the treatment of lupus nephritis with cerebral abscesses: A case report
Qiong-Dan Hu
Li-Shang Liao
Yong Zhang
Qiong Zhang
Jian Liu
World Journal of Clinical Cases, 2022, (06) : 1981 - 1990
[34] Surgery and antibiotics for the treatment of lupus nephritis with cerebral abscesses: A case report
Hu, Qiong-Dan
Liao, Li-Shang
Zhang, Yong
Zhang, Qiong
Liu, Jian
WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (06) : 1981 - 1990
[35] LeuprorelinFirst report of exacerbation of lupus nephritis: case report
Reactions Weekly, 1997, 667 (1) : 11 - 12
[36] Secukinumab on Refractory Lupus Nephritis
Costa, Rita
Antunes, Paula
Salvador, Pedro
Oliveira, Pedro
Marinho, Antonio
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
[37] Estrogen/spironolactoneSystemic lupus erythematosus and lupus nephritis: case report
Reactions Weekly, 2021, 1836 (1) : 320 - 320
[38] HydralazineClass IV lupus nephritis: case report
Reactions Weekly, 2024, 2036 (1) : 204 - 204
[39] Refractory lupus nephritis: a survey
Weidenbusch, M.
Bai, Y.
Eder, J.
Anders, H. J.
LUPUS, 2019, 28 (04) : 455 - 464
[40] HydralazineANCA vasculitis and lupus nephritis: case report
Reactions Weekly, 2016, 1607 (1) : 202 - 202

← 1 2 3 4 5 →